Quantcast

Latest NIH funding of IBS Research Stories

2014-07-08 16:25:38

LOS ANGELES, July 8, 2014 /PRNewswire/ -- Mark Pimentel, M.D., FRCP(C), FACG, Director, GI Motility Program, Professor of Medicine at Cedars-Sinai Medical Center (Cedars-Sinai), announced today the program for the upcoming 2014 Global Outreach Symposium on Irritable Bowel Syndrome (IBS). Dr. Pimentel, along with Ruchi Mathur, M.D., FRCP(C), Christopher Chang, M.D., Ph.D. and Ali Rezaie, M.D., MSc, FRCP(C)from the GI Motility Program at Cedars-Sinai,will present a one-day global...

2012-09-29 23:02:16

G-Tech has obtained IRB approval to launch a clinical research study designed to record abnormal myoelectrical activity in subjects with irritable bowel syndrome (IBS). Palo Alto, Calif. (PRWEB) September 28, 2012 G-Tech, an early stage medical device company, announced today that it has received IRB approval to launch a six-month, 60-subject clinical research study designed to record abnormal myoelectrical activity in subjects with abdominal pain associated with irritable bowel syndrome...

2011-11-21 12:26:30

A patient's viewpoint of the severity of irritable bowel syndrome (IBS) symptoms can be influenced not only by physical symptoms of IBS but broader psychological problems, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Clinicians who face pressure to treat patients in a cost-effective manner within tight time constraints and at a satisfactory level are likely to find that patient-reported outcome...

2011-06-30 12:12:00

LOS ANGELES, June 30, 2011 /PRNewswire/ -- For years, physicians have thought of chronic abdominal pain, also known as irritable bowel syndrome (IBS), as the result of an overactive nervous system. Because the root problem was determined to be essentially psychosomatic, treatment typically consisted of antidepressants. However a new study published in World Journal of Gastroenterology suggests the disorder is an immune-gastro-enterological syndrome involving many organic causes....

2011-05-11 13:47:24

Linking it to bacterial overgrowth, food poisoning Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people. One study provides further evidence that IBS is linked to an overgrowth of bacteria in the gut. In a separate study, a mathematical model reveals the disease's link to food poisoning and shows that military personnel are at a much higher...

2010-05-04 15:33:25

Most people associate serotonin with brain neurology, but over 95 percent of the body's serotonin occurs in the gastrointestinal tract, which has a complex neuronal circuit that has been called "the second brain" of the body. Now a Mayo Clinic research team has identified a number of genetic variants in serotonin genes that impact irritable bowel syndrome or IBS. The findings were presented today at Digestive Disease Week 2010 in New Orleans. IBS is one of the most common chronic disorders of...

2010-05-03 08:00:00

NEW ORLEANS, May 3 /PRNewswire/ -- Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary...

2010-04-29 01:59:00

GOTHENBURG, Sweden, April 29, 2010 /PRNewswire/ -- Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held...

2010-01-15 17:58:00

Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient's well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology. A research article to be published on December 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team from Finland quantified fourteen bacterial phylotypes which corresponded with bacterial species of...

2010-01-04 14:45:40

A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS. "Our study investigated if herbal antidepressants such as St. John's wort could benefit irritable bowel disease patients," says Yuri...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related